Fibrin Sealants Market Outlook:
Fibrin Sealants Market size was valued at USD 1.17 billion in 2025 and is set to exceed USD 2.39 billion by 2035, expanding at over 7.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of fibrin sealants is estimated at USD 1.25 billion.
The growth of the market is primarily attributed to the growing prevalence of several kinds of surgeries, the growing occurrence of blood disorders, and traumatic injuries across the globe. As per the figures provided by the World Health Organization (WHO), each year, 3.16 million individuals die as a consequence of unintentional injuries, while 1.25 million individuals die as a consequence of violence-related injuries on a worldwide level.
Fibrin sealants (FS) are protein-based medical adhesives that aid in wound closure and healing. Though bovine and porcine sources are also available, fibrin sealants are generally extracted from human blood. The fibrin sealant molecule's adhesive characteristics allow it to quickly form a clot at the site of the incision, preventing bleeding and sealing it. Fibrin sealant has also been proven to speed up epithelial cell migration, which promotes faster rates of tissue regeneration. For instance, in a clinical study, it was observed that the use of fibrin sealant in combination with photo-biomodulation therapy has shown promising outcomes in the repair of peripheral nerve injuries, as well as being efficient in the neurorrhaphy process and providing a higher quality of axonal regeneration to the interior of the distal stump.
